Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes.

    ... N, Schnittger S, Kern W, Wiedemann B, Zander AR, Haferlach T Original Publication Date:  ... The rates of allogeneic stem cell transplantation (SCT) to treat the myelodysplastic syndromes ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Outcome of Allogeneic Stem Cell Transplantation for Patients Transformed to MDS or Leukemia from Severe Aplastic Anemia. A report by the MDS subcommittee of the chronic malignancies working party (CMWP) and the severe aplastic anemia working party (WPSAA)

    ... M, Peters C, Robin M, van Biezen AA, Volin L, De Witte T, Marsh J, Passweg JR, Kröger N ...

    Research Article last updated 07/20/2018 - 5:15pm.

  3. STAT3-mutations indicate the presence of subclinical T cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.

    Journal Title:  Blood Primary Author:  Jerez A Original Publication Date:  ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Predicting response to immunosuppressive therapy in childhood aplastic anemia.

    ... Hama A, Takahashi Y, Kosaka Y, Kobayashi R, Yabe H, Kaneko T, Tsuchida M, Ohara A, Nakahata T, Kojima S. ... . In multivariate analyses, lower white blood cell count was the most significant predictive marker of better response; ...

    Research Article last updated 07/20/2018 - 5:14pm.

  5. Identification of novel microRNA signatures linked to acquired aplastic anemia

    ... investigated in acquired aplastic anemia , a T cell -mediated immune disease. Analysis of 84 miRNA expression levels in ...

    Research Article last updated 07/20/2018 - 5:15pm.

  6. The diagnosis and treatment of aplastic anemia: a review

    ... pancytopenia . A trigger-related abnormal T cell response facilitated by some genetic predisposition has been ... is not available for transplant. MSD hematopoietic stem cell transplantation (HSCT) is associated with cure in ~90 % of patients. ...

    Research Article last updated 07/20/2018 - 5:15pm.

  7. The Effect of Decitabine Dose Modification and Myelosuppression on Response and Survival in Patients With Myelodysplastic Syndromes

    ... G, Cornelison AM, Cortes JE, Ravandi F, Daver N, Kadia T, Teng A, Kantarjian H Original ... with MDS conducted Cox regression analyses of red blood cell or platelet dependence, myelosuppression, dose modification, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  8. Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

    ... Primary Author:  Rondelli T Author(s):  ... response is variable and some patients remain red blood cell transfusion -dependent. In 72 patients with hemolytic Paroxysmal ...

    Research Article last updated 07/20/2018 - 5:15pm.

  9. Infections in myelodysplastic syndromes: a review

    ... including impaired neutrophil function, B-, T-, and NK-cell defects and the possible consequences of iron overload due to ...

    Research Article last updated 07/20/2018 - 5:14pm.

  10. Lenalidomide in lower-risk myelodysplastic syndromes with karyotypes other than deletion 5q and refractory to erythropoiesis-stimulating agents

    ... Sibon D, Cannas G, Baracco F, Prebet T, Vey N, Banos A, Besson C, Corm S, Blanc M, Slama B, Perrier H, Fenaux P, ... Lenalidomide (LEN) has been shown to yield red blood cell (RBC) transfusion independence in about 25% of lower risk ...

    Research Article last updated 07/20/2018 - 5:14pm.